
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex is positioned for a positive financial outlook due to a projected sales growth trend of approximately 6% off a substantial near $1 billion base, driven by its interventional business and strategic acquisitions. The company anticipates moderate operating margin improvement and double-digit earnings growth, supported by revenue growth initiatives and cost reduction efforts. Additionally, ongoing product launches and a favorable shift towards higher-margin offerings, along with a historical correlation between growth prospects and valuation premium, further bolster confidence in Teleflex's future performance.
Bears say
Teleflex's financial outlook appears negative due to several key factors: the company reported a decline in GAAP revenue growth, forecasting a range of -0.4% to 0.7%, which falls significantly short of expectations for organic growth in the 1-2% range. Additionally, the guidance for 2025 indicates lower anticipated earnings per share (EPS) and revenue, with estimates substantially lower than consensus, reflecting challenges in critical areas such as the UroLift product line and ongoing price pressures. Furthermore, risks associated with larger acquisitions and slower-than-expected growth from pivotal business segments contribute to the overall lack of confidence in the stock's performance moving forward.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares